E43K (p.Glu43Lys) variant of SGCA (Alpha-sarcoglycan)
E43K (p.Glu43Lys) in SGCA (Alpha-sarcoglycan) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
E43K (p.Glu43Lys) variant details
- p.Glu43Lys
- NCI-TCGA Cosmic COSV5624
- cosmic curated COSV56249
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available